華特氣體(688268.SH):擬在江蘇省如東沿海經濟開發區建生產基地
格隆匯9月26日丨華特氣體(688268.SH)公佈,為促進公司的發展,推進公司在江蘇地區的戰略佈局,公司擬與江蘇省如東沿海經濟開發區管理委員會簽訂《<華特氣體電子化學品生產基地項目>項目建設協議書》,在江蘇省如東沿海經濟開發區建設生產基地,通過招拍掛方式取得項目用地。項目總投資5億元,其中設備投資不低於總投資的40%,投資強度不低於450萬元/畝(不含流動資金)。公司將根據戰略規劃、經營計劃、資金情況和協議約定進行建設。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.